| MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer X Wu, Q Luo, P Zhao, W Chang, Y Wang, T Shu, F Ding, B Li, Z Liu Proceedings of the National Academy of Sciences 116 (8), 2961-2966, 2019 | 68 | 2019 |
| JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1 X Wu, Q Luo, P Zhao, W Chang, Y Wang, T Shu, F Ding, B Li, Z Liu Cell Death & Differentiation 27 (1), 55-70, 2020 | 56 | 2020 |
| Ubiquitination and deubiquitination of MCL1 in cancer: deciphering chemoresistance mechanisms and providing potential therapeutic options X Wu, Q Luo, Z Liu Cell death & disease 11 (7), 556, 2020 | 54 | 2020 |
| TRIM32/USP11 balances ARID1A stability and the oncogenic/tumor-suppressive status of squamous cell carcinoma Q Luo, X Wu, Y Nan, W Chang, P Zhao, Y Zhang, D Su, Z Liu Cell Reports 30 (1), 98-111. e5, 2020 | 45 | 2020 |
| OTUD1 activates caspase‐independent and caspase‐dependent apoptosis by promoting AIF nuclear translocation and MCL1 degradation Q Luo, X Wu, P Zhao, Y Nan, W Chang, X Zhu, D Su, Z Liu Advanced Science 8 (8), 2002874, 2021 | 44 | 2021 |
| ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2 Q Luo, X Wu, Y Zhang, T Shu, F Ding, H Chen, P Zhao, W Chang, X Zhu, ... Cancer letters 427, 9-17, 2018 | 38 | 2018 |
| ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness Q Luo, X Wu, W Chang, P Zhao, Y Nan, X Zhu, JP Katz, D Su, Z Liu Cell Death & Differentiation 27 (6), 1981-1997, 2020 | 30 | 2020 |
| ARID1A hypermethylation disrupts transcriptional homeostasis to promote squamous cell carcinoma progression Q Luo, X Wu, W Chang, P Zhao, X Zhu, H Chen, Y Nan, A Luo, X Zhou, ... Cancer research 80 (3), 406-417, 2020 | 27 | 2020 |
| Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer Y Zhang, F Huang, Q Luo, X Wu, Z Liu, H Chen, Y Huang OncoTargets and therapy, 8751-8759, 2018 | 20 | 2018 |
| The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP X Zhu, Y Zhang, Q Luo, X Wu, F Huang, T Shu, Y Wan, H Chen, Z Liu Signal Transduction and Targeted Therapy 6 (1), 264, 2021 | 15 | 2021 |
| HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity Y Nan, Q Luo, X Wu, W Chang, P Zhao, S Liu, Z Liu Molecular Therapy 31 (2), 552-568, 2023 | 11 | 2023 |
| DLGAP1-AS2–Mediated phosphatidic acid synthesis activates YAP signaling and confers chemoresistance in squamous cell carcinoma Y Nan, Q Luo, X Wu, S Liu, P Zhao, W Chang, A Zhou, Z Liu Cancer Research 82 (16), 2887-2903, 2022 | 11 | 2022 |
| OTUB2 exerts tumor-suppressive roles via STAT1-mediated CALML3 activation and increased phosphatidylserine synthesis W Chang, Q Luo, X Wu, Y Nan, P Zhao, L Zhang, A Luo, W Jiao, Q Zhu, ... Cell reports 41 (4), 2022 | 10 | 2022 |
| Remodeling of the ARID1A tumor suppressor Q Luo, X Wu, Z Liu Cancer Letters 491, 1-10, 2020 | 9 | 2020 |
| RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression X Yu, P Zhao, Q Luo, X Wu, Y Wang, Y Nan, S Liu, W Gao, B Li, Z Liu, ... Oncogene 43 (6), 420-433, 2024 | 2 | 2024 |
| DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Confers Chemoresistance via Activation of YAP Signaling Y Nan, Q Luo, X Wu, S Liu, P Zhao, W Chang, A Zhou, Z Liu BioRxiv, 2022.02. 24.481869, 2022 | 2 | 2022 |
| m6A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell-cycle progression and HIF-1α activation Y Nan, S Liu, Q Luo, X Wu, P Zhao, W Chang, R Zhang, Y Li, Z Liu Cell Reports 42 (10), 2023 | 1 | 2023 |
| OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition Y Nan, X Wu, Q Luo, W Chang, P Zhao, L Zhang, Z Liu Proceedings of the National Academy of Sciences 121 (19), e2315348121, 2024 | | 2024 |
| Corrigendum to'ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2'[Canc. Lett. 427 (2018) 9-17] Q Luo, X Wu, Y Zhang, T Shu, F Ding, H Chen, P Zhao, W Chang, X Zhu, ... Cancer letters 498, 243, 2021 | | 2021 |
| Correction: ARID1A Hypermethylation Disrupts Transcriptional Homeostasis to Promote Squamous Cell Carcinoma Progression Q Luo, X Wu, W Chang, P Zhao, X Zhu, H Chen, Y Nan, A Luo, X Zhou, ... Cancer Research 80 (19), 4302-4302, 2020 | | 2020 |
